-
51
المصدر: Current Pharmacology Reports. 6:241-259
مصطلحات موضوعية: 0301 basic medicine, Pharmacology, Prothrombin time, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Biochemistry, Dabigatran, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Coagulation, Direct thrombin inhibitor, 030220 oncology & carcinogenesis, Pharmacodynamics, Drug Discovery, Genetics, medicine, Oral vitamin, Intensive care medicine, business, Case discussion, medicine.drug, Partial thromboplastin time
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::aa7b916f6406804903d1ac400be002caTest
https://doi.org/10.1007/s40495-020-00232-7Test -
52
المؤلفون: Holleh D Husseinzadeh, Jerald Z. Gong, Kaitlyn C. Dykes, Cassandra A. Johnson, Steven E. McKenzie
المصدر: Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Clinical and Applied Thrombosis/Hemostasisمصطلحات موضوعية: Male, medicine.medical_specialty, anticoagulants, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.drug_class, medicine.medical_treatment, adverse event, factor Xa inhibitors, Hemorrhage, 030204 cardiovascular system & hematology, Fondaparinux, Argatroban, 03 medical and health sciences, 0302 clinical medicine, Heparin-induced thrombocytopenia, medicine, Humans, 030212 general & internal medicine, direct thrombin inhibitor, Retrospective Studies, business.industry, Heparin, Anticoagulant, Thrombosis, Hematology, General Medicine, Middle Aged, medicine.disease, Thrombocytopenia, Pre- and post-test probability, Clinical trial, Direct thrombin inhibitor, lcsh:RC666-701, Emergency medicine, Original Article, Female, heparin-induced thrombocytopenia, business, Watchful waiting, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a6a484793d33b8a99a71075ebaffa5bTest
https://doaj.org/article/56048efea18f42748d5c41e4274db7e1Test -
53
المؤلفون: Leah Militello, Hannah L McRae, Majed A. Refaai
المصدر: Biomedicines
Biomedicines, Vol 9, Iss 262, p 262 (2021)مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_mechanism_of_action, medicine.drug_class, Point-of-care testing, Factor Xa Inhibitor, Medicine (miscellaneous), Low molecular weight heparin, direct oral anticoagulant, Review, 030204 cardiovascular system & hematology, heparin, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, anticoagulation monitoring, medicine, 030212 general & internal medicine, Dosing, coagulation, Intensive care medicine, anticoagulation, lcsh:QH301-705.5, direct thrombin inhibitor, point of care testing, business.industry, low molecular weight heparin, Anticoagulant, anticoagulant, Warfarin, warfarin, lcsh:Biology (General), Direct thrombin inhibitor, business, Discovery and development of direct thrombin inhibitors, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bfda90e74147501421456336a47d2f8Test
http://europepmc.org/articles/PMC8001784Test -
54دورية أكاديمية
المؤلفون: S. Baldelli, D. Cattaneo, M. Cerea, P. Pignatelli, F. Violi, E. Clementi
المساهمون: S. Baldelli, D. Cattaneo, M. Cerea, P. Pignatelli, F. Violi, E. Clementi
مصطلحات موضوعية: direct thrombin inhibitor, pharmacodynamic, pharmacokinetic, determinant, variability, rivaroxaban, etexilate, apixaban, plasma, Settore BIO/14 - Farmacologia
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27855135; info:eu-repo/semantics/altIdentifier/wos/WOS:000388894900026; volume:38; issue:6; firstpage:814; lastpage:816; numberofpages:3; journal:THERAPEUTIC DRUG MONITORING; http://hdl.handle.net/2434/463105Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84996483278
-
55دورية أكاديمية
المؤلفون: Jumeau, Céline, Rupin, Alain, Chieng-Yane, Pauline, Mougenot, Nathalie, Zahr, Noël, David-Dufilho, Monique, Hatem, Stéphane N.
المساهمون: Institut de Recherches Internationales Servier Suresnes (IRIS), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), FRS Consulting, Phénotypage du petit animal (UMS28), Université Pierre et Marie Curie - Paris 6 (UPMC), Centre d'investigation clinique Paris Est CHU Pitié Salpêtrière (CIC Paris-Est), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), This work was supported by the Servier Research Institute and Laboratories, (contract n°122694/BR/VO), the Agence Nationale de la Recherche (ANR), Paris (National program “Investissements d'avenir”: ANR-10-IAHU-05), and the European Network for Translational Research in AF (FP7 EUTRAF- 261057 and H2020CATCH-ME 633196). Dr. Jumeau received a CIFRE grant from the French Ministry of Education and Research, Paris (2012-0374)., ANR-10-IAHU-0005,ICAN,Institut de Cardiologie-Métabolisme-Nutrition(2010), European Project: 261057,EC:FP7:HEALTH,FP7-HEALTH-2010-single-stage,EUTRAF(2010), European Project: 633196,H2020,H2020-PHC-2014-two-stage,CATCH ME(2015)
المصدر: ISSN: 2452-302X.
مصطلحات موضوعية: Direct thrombin inhibitor, Remodeling, Anticoagulant, Atrial arrhythmia, Heart failure, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
العلاقة: info:eu-repo/grantAgreement/EC/FP7/261057/EU/The European Network for Translational Research in Atrial Fibrillation/EUTRAF; info:eu-repo/grantAgreement//633196/EU/Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly/CATCH ME; hal-01357965; https://hal.sorbonne-universite.fr/hal-01357965Test; https://hal.sorbonne-universite.fr/hal-01357965/documentTest; https://hal.sorbonne-universite.fr/hal-01357965/file/j.jacbts.2016.05.002.full.pdfTest
الإتاحة: https://doi.org/10.1016/j.jacbts.2016.05.002Test
https://hal.sorbonne-universite.fr/hal-01357965Test
https://hal.sorbonne-universite.fr/hal-01357965/documentTest
https://hal.sorbonne-universite.fr/hal-01357965/file/j.jacbts.2016.05.002.full.pdfTest -
56دورية أكاديمية
المؤلفون: Hui Lim, Prahlad Ho
المصدر: Dentistry Journal; Volume 4; Issue 1; Pages: 7
مصطلحات موضوعية: direct oral anticoagulants, factor Xa inhibitor, direct thrombin inhibitor, bleeding, frail elderly
وصف الملف: application/pdf
-
57
المؤلفون: Igor Tartakovsky, Martina Brueckmann, Lesley G. Mitchell, Fenglei Huang, Hugo Maas, Joachim Stangier, Savion Gropper, Jacqueline Halton
المصدر: Thrombosis and Haemostasis
مصطلحات موضوعية: Adult, Male, anticoagulants, medicine.medical_specialty, Stroke, Systemic or Venous Thromboembolism, Adolescent, medicine.drug_class, Thrombin Time, venous thromboembolism, 030204 cardiovascular system & hematology, Thrombin time, Dabigatran, paediatrics, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Child, Blood Coagulation, direct thrombin inhibitor, Aged, Aged, 80 and over, Hemostasis, medicine.diagnostic_test, business.industry, Anticoagulant, Infant, Hematology, Middle Aged, Clinical trial, Direct thrombin inhibitor, Female, Partial Thromboplastin Time, Ecarin clotting time, business, circulatory and respiratory physiology, 030215 immunology, Partial thromboplastin time, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27e96bc21fabfd6d20bb01ab186fc46Test
https://doi.org/10.1055/s-0038-1668132Test -
58
المؤلفون: Mark Schreuder, Pieter H. Reitsma, Mettine H.A. Bos
المصدر: Seminars in Thrombosis and Hemostasis. 46:986-998
مصطلحات موضوعية: biology, business.industry, Anticoagulants, Idarucizumab, Hematology, 030204 cardiovascular system & hematology, Pharmacology, Prothrombin complex concentrate, Dabigatran, Review article, 03 medical and health sciences, 0302 clinical medicine, Thrombin, Recombinant factor VIIa, Direct thrombin inhibitor, Hemostasis, biology.protein, Humans, Medicine, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Factor Xa Inhibitors, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb49b5ee0c496de367c4ecb40017c31cTest
https://doi.org/10.1055/s-0040-1709134Test -
59
المؤلفون: Shelby L. Johnson, Jaclyn Iannucci, Navindra P. Seeram, Paula Grammas
المصدر: Biochemical and Biophysical Research Communications. 527:532-538
مصطلحات موضوعية: Male, 0301 basic medicine, Parkinson's disease, Biophysics, Pharmacology, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, medicine.disease_cause, Biochemistry, Antithrombins, Animals, Genetically Modified, 03 medical and health sciences, 0302 clinical medicine, Thrombin, medicine, Animals, Humans, Molecular Biology, Neuroinflammation, biology, business.industry, Dopaminergic, Parkinson Disease, Cell Biology, biology.organism_classification, medicine.disease, LRRK2, Dabigatran, Disease Models, Animal, Oxidative Stress, Drosophila melanogaster, 030104 developmental biology, Direct thrombin inhibitor, 030220 oncology & carcinogenesis, Mutation, Female, business, Locomotion, Oxidative stress, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb754f191c3ab0789a30e92559096e6cTest
https://doi.org/10.1016/j.bbrc.2020.04.068Test -
60
المؤلفون: Paal Skytt Andersen, Christian Torp-Pedersen, Andreas Petersen, Gunnar Gislason, Henning Bundgaard, Kasper Iversen, Lars Køber, Emil L. Fosbøl, Niels Eske Bruun, Jawad H. Butt, Thomas A. Gerds, Robert Skov, Anders Rhod Larsen, Peter Verhamme, Jonas Bjerring Olesen
المصدر: Butt, J H, Fosbøl, E L, Verhamme, P, Gerds, T A, Iversen, K, Bundgaard, H, Bruun, N E, Larsen, A R, Petersen, A, Andersen, P S, Skov, R L, Gislason, G H, Torp-Pedersen, C, Køber, L & Olesen, J B 2021, ' Dabigatran and the Risk of Staphylococcus aureus Bacteremia : A Nationwide Cohort Study ', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 73, no. 3, pp. 480-486 . https://doi.org/10.1093/cid/ciaa661Test
Butt, J H, Fosbøl, E L, Verhamme, P, Gerds, T A, Iversen, K, Bundgaard, H, Bruun, N E, Larsen, A R, Petersen, A, Andersen, P S, Skov, R L, Gislason, G H, Torp-Pedersen, C, Køber, L & Olesen, J B 2021, ' Dabigatran and The Risk of Staphylococcus Aureus Bacteremia : A Nationwide Cohort Study ', Clinical Infectious Diseases, vol. 73, no. 3, ciaa661, pp. 480–486 . https://doi.org/10.1093/cid/ciaa661Testمصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), Staphylococcus aureus, medicine.medical_specialty, Administration, Oral, Bacteremia, 030204 cardiovascular system & hematology, Rate ratio, Dabigatran, Cohort Studies, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Edoxaban, Internal medicine, Humans, Medicine, dabigatran, Rivaroxaban, business.industry, Atrial fibrillation, S. aureus, medicine.disease, Stroke, 030104 developmental biology, Infectious Diseases, chemistry, Direct thrombin inhibitor, epidemiology, Apixaban, Warfarin, business, medicine.drug, Cohort study
وصف الملف: application/pdf; Print
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1699dba73779d4814a653fb50d609aTest
https://doi.org/10.1093/cid/ciaa661Test